APP and Alzheimer disease: Although studies indicate that there is a potential link between O-GlcNAcylation of APP and the Aβ load in AD patients, it is important to bear in mind that other AD-related molecules are O-glycosylated, and could thus contribute to the effects seen by altered glycosylation (Schedin-Weiss et al., 2014).